ATE243993T1 - Verwendung von 5ht3 antagonisten zum fördern der darmspülung - Google Patents

Verwendung von 5ht3 antagonisten zum fördern der darmspülung

Info

Publication number: ATE243993T1
Authority: AT; Austria
Prior art keywords: antagonists; flushment; promote intestinal; intestinal; promote
Prior art date: 1997-04-18

Application number

AT98922759T

Other languages

English (en)

Inventor

Antonius Adrianus Hendr Megens

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-18

Filing date

1998-04-14

Publication date

2003-07-15

1998-04-14 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2003-07-15 Application granted granted Critical

2003-07-15 Publication of ATE243993T1 publication Critical patent/ATE243993T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines Containing Plant Substances (AREA)

AT98922759T 1997-04-18 1998-04-14 Verwendung von 5ht3 antagonisten zum fördern der darmspülung ATE243993T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP97201149		1997-04-18
PCT/EP1998/002356 WO1998047481A1 (en)	1997-04-18	1998-04-14	Use of 5ht3 antagonists for promoting intestinal lavage

Publications (1)

Publication Number	Publication Date
ATE243993T1 true ATE243993T1 (de)	2003-07-15

Family

ID=8228223

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98922759T ATE243993T1 (de)	1997-04-18	1998-04-14	Verwendung von 5ht3 antagonisten zum fördern der darmspülung

Country Status (12)

Country	Link
US (2)	US6235745B1 (de)
EP (1)	EP0975327B1 (de)
JP (1)	JP2001523239A (de)
KR (1)	KR100529512B1 (de)
AT (1)	ATE243993T1 (de)
AU (1)	AU745361B2 (de)
CA (1)	CA2286076C (de)
DE (1)	DE69816060T2 (de)
DK (1)	DK0975327T3 (de)
ES (1)	ES2202855T3 (de)
PT (1)	PT975327E (de)
WO (1)	WO1998047481A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1090638A1 (de) *	1999-10-08	2001-04-11	Sanofi-Synthelabo	Verwendung von (R)-Zacopride oder dessen Salz zur Herstellung eines Medikaments für die Behandlung von Schlafapnoe
US20040096423A1 (en) *	2000-11-24	2004-05-20	Megens Antonius Adrianus Hendrikus Petrus	Use of a triple combination comprising a 5ht3 antagonist, a 5ht4agonist and a laxative for promoting intestinal lavage
PE20021019A1 (es)	2001-04-19	2002-11-13	Upjohn Co	Grupos azabiciclicos sustituidos
US20040048874A1 (en) *	2001-05-22	2004-03-11	Bardsley Hazel Judith	New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) *	2002-07-10	2002-08-21	Arachnova Therapeutics Ltd	New therapeutic use
TWI332943B (en) *	2001-07-10	2010-11-11	Synta Pharmaceuticals Corp	Taxol enhancer compounds
US6946149B2 (en) *	2002-04-30	2005-09-20	Braintree Laboratories, Inc.	Salt solution for colon cleansing
JP2006503864A (ja) *	2002-10-01	2006-02-02	ジヨンソン・アンド・ジヨンソン・フアーマシユーチカル・リサーチ・アンド・デベロツプメント・インコーポレーテツド	タンパク質チロシンキナーゼ阻害剤としての４，６−ジアミノ置換−２−［オキシ又はアミノキシ］−［１，３，５］トリアジン
US6996500B2 (en) *	2002-10-30	2006-02-07	Hewlett-Packard Development Company, L.P.	Method for communicating diagnostic data
MXPA05007381A (es) *	2003-01-13	2006-02-10	Dynogen Pharmaceuticals Inc	Metodo para el tratamiento de transtornos funcionales del intestino.
EP1567163B1 (de) *	2003-01-13	2007-04-11	Dynogen Pharmaceuticals Inc.	Verfahren zur behandlung von übelkeit, erbrechen, würgereiz oder jede kombination daraus
JP2006522144A (ja) *	2003-04-04	2006-09-28	ダイノゲンファーマシューティカルズ，インコーポレイテッド	下部尿路障害の治療方法
US7049319B2 (en) *	2003-09-23	2006-05-23	Semaan Abboud	Colon cleansing composition and method
US20070155780A1 (en) *	2004-04-15	2007-07-05	Hitoshi Nakata	Stabilized composition containing 4-amino-5-chloro-n-[(1r, 3r, 5s)-8-methyl-8-azabicyclo[3.2.1]oct-3-y1]-2-[1-methylbut-2-ynyloxy]benzamide
WO2006105117A2 (en) *	2005-03-28	2006-10-05	Dynogen Pharmaceuticals, Inc.	Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
WO2007019888A2 (en) *	2005-08-12	2007-02-22	Ctg Pharma S.R.L.	Therapeutic compositions containing mesalamine and a co-agent for treating colon diseases
CA2618723C (en) *	2005-08-16	2014-05-27	Synta Pharmaceuticals Corp.	Bis(thio-hydrazide amide) formulation
EP1928437A2 (de) *	2005-08-26	2008-06-11	Braincells, Inc.	Neurogenese mittels muscarinrezeptormodulation
MX2009001494A (es)	2006-08-07	2009-04-23	Albany Molecular Res Inc	2-aminobenzoxazol carboxamidas como moduladores 5ht3.
US7553846B2 (en)	2006-08-07	2009-06-30	Albany Molecular Research, Inc.	2-alkylbenzoxazole carboxamides as 5-HT3 modulators
US9545446B2 (en)	2013-02-25	2017-01-17	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase and their uses
PT2968174T (pt)	2013-03-15	2020-01-15	Braintree Laboratories Inc	Comprimidos de duplo uso oral em composições farmacêuticas de sais de sulfato e seus métodos de utilização
US10172833B2 (en)	2015-08-11	2019-01-08	Insys Development Company, Inc.	Sublingual ondansetron spray
US10143656B1 (en)	2017-08-04	2018-12-04	Braintree Laboratories, Inc.	Solid oral sulfate salt formulations for cleaning a colon and methods of using same
EP3858828A4 (de) *	2018-09-28	2022-07-06	Takeda Pharmaceutical Company Limited	Heterocyclische verbindung
US12239659B2 (en)	2023-06-15	2025-03-04	Braintree Laboratories, Inc.	Methods of administering safe colon cleansing compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB893267A (en)	1958-11-25	1962-04-04	Sterling Drug Inc	Laxative enemas
US5166145A (en) *	1990-09-10	1992-11-24	Alza Corporation	Antiemetic therapy
TW294595B (de)	1992-11-20	1997-01-01	Janssen Pharmaceutica Nv
WO1996014071A1 (es)	1994-11-04	1996-05-17	Legarda Ibanez Juan Jose	Combinacion de farmacos como medicamento destinado a supresion de dependencia de individuos a opiaceos
US6103734A (en)	1994-11-04	2000-08-15	Legarda Ibanez; Juan Jose	Drug combination as a medicament to suppress the dependence of individuals to opiates
US5576317A (en) *	1994-12-09	1996-11-19	Pfizer Inc.	NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

1998
- 1998-04-14 PT PT98922759T patent/PT975327E/pt unknown
- 1998-04-14 DK DK98922759T patent/DK0975327T3/da active
- 1998-04-14 EP EP98922759A patent/EP0975327B1/de not_active Expired - Lifetime
- 1998-04-14 US US09/403,248 patent/US6235745B1/en not_active Expired - Lifetime
- 1998-04-14 WO PCT/EP1998/002356 patent/WO1998047481A1/en active IP Right Grant
- 1998-04-14 JP JP54502298A patent/JP2001523239A/ja not_active Ceased
- 1998-04-14 ES ES98922759T patent/ES2202855T3/es not_active Expired - Lifetime
- 1998-04-14 DE DE69816060T patent/DE69816060T2/de not_active Expired - Lifetime
- 1998-04-14 AU AU75282/98A patent/AU745361B2/en not_active Ceased
- 1998-04-14 CA CA002286076A patent/CA2286076C/en not_active Expired - Lifetime
- 1998-04-14 AT AT98922759T patent/ATE243993T1/de not_active IP Right Cessation
- 1998-04-14 KR KR10-1999-7007936A patent/KR100529512B1/ko not_active IP Right Cessation
2001
- 2001-03-08 US US09/801,978 patent/US6555546B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US6555546B2 (en)	2003-04-29
DE69816060D1 (de)	2003-08-07
EP0975327B1 (de)	2003-07-02
US6235745B1 (en)	2001-05-22
CA2286076A1 (en)	1998-10-29
KR20000075858A (ko)	2000-12-26
EP0975327A1 (de)	2000-02-02
DE69816060T2 (de)	2004-04-22
JP2001523239A (ja)	2001-11-20
ES2202855T3 (es)	2004-04-01
AU745361B2 (en)	2002-03-21
PT975327E (pt)	2003-11-28
US20010020025A1 (en)	2001-09-06
KR100529512B1 (ko)	2005-11-22
CA2286076C (en)	2006-12-12
WO1998047481A1 (en)	1998-10-29
AU7528298A (en)	1998-11-13
DK0975327T3 (da)	2003-10-20

Publication	Publication Date	Title
ATE243993T1 (de)	2003-07-15	Verwendung von 5ht3 antagonisten zum fördern der darmspülung
DE69819311D1 (de)	2003-12-04	Neue benzimidazol inhibitoren der fructose-1,6-bisphosphatase
TR200000782T2 (tr)	2000-09-21	Resorsinol türevleri.
FI964004A0 (fi)	1996-10-04	Serotoniiniantagonistien (5HT3) käyttö fibromyalgian hoitoon
CU22997A3 (es)	2004-10-12	Proteína híbrida para la inhibición de la desgranulación de los mastocitos y su utilización
TR970073A2 (tr)	1997-02-21	Alfa adrenerjik resentör antagonistleri olarak pirimidindion pirimidintrion,triazindion, tetrahidrokinazolindion türevleri.
EA199900693A1 (ru)	2000-02-28	Атропизомеры 3-арил-4(3h)-хиназолинонов и их использование в качестве антагонистов амра-рецепторов
DE3785615D1 (de)	1993-06-03	Hemmungsstoffe der serin-protease.
ATE233274T1 (de)	2003-03-15	Oxyiminopregnancarbolactone
SE9702773D0 (sv)	1997-07-22	Novel compounds
DK1083903T3 (da)	2005-01-03	Brobundne indenopyrrolocarbazoler
TR200002896T2 (tr)	2001-01-22	Kalsilitik Bileşimler
EA200000536A1 (ru)	2000-10-30	Применение комбинации ингибитора конвертирующего фермента и диуретика для лечения нарушений микроциркуляции
DE69804198D1 (de)	2002-04-18	Zementschlamm für die zementierung von bohrlöchern insbesondere ölbohrlöchern
DE69114328D1 (de)	1995-12-14	Überwachung von Mikroprozessoren.
EA200100517A1 (ru)	2001-12-24	Антагонисты 5ht1 для антидепрессантной терапии
PT696194E (pt)	2002-11-29	Utilizacao de derivados de indole como antagonistas de 5ht1
TR200102742T2 (tr)	2002-05-21	Rezorsinol türevleri
TR200001080T2 (tr)	2001-01-22	2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
PE20399A1 (es)	1999-03-05	Muteina ob
DE59803066D1 (de)	2002-03-21	Substituierte benzyloxyimino-verbindungen
TR200003203T2 (tr)	2001-03-21	Karboksaldehitin saflaştırılması
DE59808166D1 (de)	2003-06-05	Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure als mukolytikum
ATE25247T1 (de)	1987-02-15	4-amino-3-imidazolin-2-on und (2-methoxy-2-imino- ethyl)-harnstoff, ihre herstellung und verwendung.
EA199900959A1 (ru)	2000-06-26	Способы снижения содержания фибриногена

Legal Events

Date	Code	Title	Description
2004-04-15	UEP	Publication of translation of european patent specification	Ref document number: 0975327 Country of ref document: EP
2011-01-15	REN	Ceased due to non-payment of the annual fee

Date

Code

Title

Description

2004-04-15

UEP

Publication of translation of european patent specification

Ref document number: 0975327

Country of ref document: EP

2011-01-15

REN

Ceased due to non-payment of the annual fee